Suvoda
Suvoda provides enterprise SaaS for clinical trial management, offering a unified platform with RTSM/IRT, eCOA, eConsent, patient payments, travel, and budgeting modules to pharmaceutical sponsors, CROs, research sites, and trial patients across 115+ countries.
- Company typePrivate
- Founded2013
- HeadquartersConshohocken, United States
- Headcount1,001–5,000
- GTM typeB2B
- OfferingSoftware
What Suvoda does
Suvoda is a privately held clinical trial technology company founded in 2013 and headquartered in Conshohocken, Pennsylvania, that provides enterprise software and services for pharmaceutical sponsors, contract research organizations (CROs), research sites, and clinical trial patients. Its unified platform comprises eight interconnected products: RTSM/IRT for randomization and drug supply management, eCOA for electronic clinical outcome assessments, eConsent for digital consent, Scheduling, a unified Patient App, Site Payments, Greenphire Patient Payments (ClinCard), Greenphire Travel (ConneX), and Budgeting & Benchmarking. The platform is built on a patented low-code/no-code architecture featuring a patented Virtual Partition multi-tenant design that maintains strict data separation and blinding across trials. Suvoda serves more than 1,000 clients across 115+ countries and has supported over 6,000 clinical trials, with 34% of FDA-approved trials since 2024 running on the platform and 65% of trials concentrated in oncology, rare disease, and CNS therapeutic areas.
Suvoda's revenue model is enterprise SaaS subscription-based with multi-year contracts, sold through direct field sales to large pharmaceutical companies, biotech firms, and CROs. Pricing is quote-based and varies by study scope, site count, geographic coverage, and module selection, with professional services attached for implementation and ongoing support. Following the April 2025 merger with Greenphire, the company expanded its platform to integrate patient payment and travel logistics alongside operational modules, creating an end-to-end clinical trial technology and financial management offering under the Suvoda name with backing from Thoma Bravo and Bain Capital Tech Opportunities.
The company is currently deploying two AI capabilities as differentiators: Sofia, a conversational AI assistant embedded in the IRT/RTSM platform with a three-layer deterministic architecture; and Agentic RTSM, which uses multiple AI agents to automate study builds, configuration, customization, and testing, with claimed reductions in trial startup timelines of up to 80%. Suvoda maintains offices in Conshohocken, Bucharest, Barcelona, and Tokyo, holds five patents with additional applications pending, and operates under GDPR, CCPA, and EU-U.S. Data Privacy Framework compliance to support cross-border data flows.
Suvoda firmographics
Firmographics- Name
- Suvoda
- Legal name
- Suvoda LLC
- Website
- https://suvoda.com
- Company type
- Private
- Founded year
- 2013
- Operating status
- Operating
- Headcount range
- 1,001–5,000 employees
- Short description
- Suvoda provides enterprise SaaS for clinical trial management, offering a unified platform with RTSM/IRT, eCOA, eConsent, patient payments, travel, and budgeting modules to pharmaceutical sponsors, CROs, research sites, and trial patients across 115+ countries.
- Ownership category
- akta.pro rank
Suvoda industry classification
Industry- Product category
- Clinical Trial Technology / eClinical Software
- NAICS
- Software Publishers (513210), Computer Systems Design and Related Services (5415)
- SIC
- Services-Prepackaged Software (7372), Services-Computer Integrated Systems Design (7373)
- akta.pro primary industry
- Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF) (HLAGAJAM)
- akta.pro secondary industry
- Site & Investigator Platforms (Site Payments, Feasibility, Activation) (HLACAOAJ)
Keywords
Where Suvoda is headquartered
LocationHeadquarters
- HQ city
- Conshohocken
- HQ country
- United States
- HQ region
- North America
Offices4 records
Markets served
Suvoda business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure
Revenue model
- Clinical Trial Software Platform: Suvoda generates revenue through enterprise SaaS licensing of its clinical trial technology platform, which includes modules for RTSM/IRT, eCOA, eConsent, Scheduling, Patient Payments, Travel, Budgeting & Benchmarking, and Site Payments. The company offers a unified platform approach following the merger with Greenphire. Revenue is generated through multi-year contracts with pharmaceutical sponsors, CROs, and research sites, typically structured as subscription-based licensing with professional services for implementation and support.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Multi-year contract | Enterprise SaaS licensing with modular pricing |
Go-to-market motion1 record
Distribution channels1 record
Marketing channels8 records
Suvoda product offering
Product offeringCore offering
Suvoda sells a unified, web-based clinical trial technology platform comprising eight modular products—RTSM/IRT, eCOA, eConsent, Patient Payments, Travel, Scheduling, Site Payments, and Budgeting & Benchmarking—delivered as multi-year enterprise SaaS subscriptions to pharmaceutical sponsors, CROs, and research sites. The platform is augmented by AI capabilities including the Sofia assistant and agentic RTSM, and supported by professional services for implementation, integration, and ongoing customer success.
Product overview
Suvoda offers a unified clinical trial technology platform with eight interconnected products organized as a core platform plus modular solutions. The platform includes RTSM (IRT) for randomization and drug supply management, eCOA for electronic clinical outcome assessments, and eConsent for digital consent management. Following the 2025 merger with Greenphire, the platform expanded to include Greenphire Patient Payments (ClinCard) for participant stipends and reimbursements, and Greenphire Travel (ConneX) for travel logistics. Additional modules include Scheduling for visit management, a unified Patient App consolidating multiple patient-facing functions, Site Payments for investigator grants, and Budgeting & Benchmarking for financial planning with split budget support. The platform is powered by a patented low-code/no-code architecture and supports AI capabilities including the Sofia AI assistant and agentic RTSM for automated study configuration.
Differentiator
Problem solved
Functional benefit
Brands
- Greenphire Patient Payments: Patient payment and reimbursement solutions for clinical trial participants
- Greenphire Travel
- Sofia
- ClinCard
- ConneX
- Clincierge
Products and services
- Suvoda Platform A unified clinical trial technology platform interconnecting RTSM, eCOA, eConsent, patient payments, travel, scheduling, site payments, and budgeting modules into a single ecosystem with real-time data synchronization across trial stakeholders. Designed for pharmaceutical sponsors, CROs, and research sites.
- RTSM (IRT) Randomization and Trial Supply Management system with Interactive Response Technology capabilities for managing patient randomization, drug allocation, and supply chain logistics in clinical trials. Used by pharmaceutical sponsors and CROs across global trials.
- eCOA Electronic Clinical Outcome Assessments solution for collecting patient-reported, clinician-reported, and observer-reported outcomes through digital questionnaires. Used by sponsors and CROs to capture trial endpoint data.
- eConsent Electronic consent solution enabling digital informed consent management for clinical trial participants, with integrated consent documentation and tracking across sites and studies.
- Greenphire Patient Payments (ClinCard) Patient payment and reimbursement solution (formerly ClinCard) for managing stipends, travel reimbursements, and participant payments with automated disbursement and receipt tracking. Used by sponsors, CROs, and research sites to reimburse clinical trial participants.
- Greenphire Travel (ConneX) Patient travel and logistics service (ConneX) for managing transportation, accommodation, and travel arrangements to reduce participation barriers for clinical trial participants. Used by sponsors and research sites.
- Scheduling Visit scheduling module for managing patient appointments, site visit calendars, and study timeline coordination across trial sites. Used by sponsors, CROs, and sites to coordinate clinical trial visits.
- Patient App Unified mobile application consolidating visit scheduling, health questionnaires, travel information, receipt submission, and payment management into a single patient experience for clinical trial participants.
- Site Payments Investigator grant and site payment management solution for automating invoice generation, approval workflows, and payment execution to research sites conducting clinical trials.
- Budgeting & Benchmarking Clinical trial financial planning solution with real-time fair market value benchmarking for site cost data, budget negotiation support, and multi-payee split budget management. Used by sponsors and CROs to negotiate and manage site budgets.
Quantifiable outcome
- Reduces clinical trial startup timelines by up to 80%
- +5 more outcomes
Companies that use Suvoda
Customer profileNamed customers9 records
Segments4 records
Ideal customer profiles4 records
Suvoda technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration2 records
AI capability7 records
Feature5 records
Suvoda partnerships and signals
Strategic signalPartnerships
Two partnerships are on record, tiered core and flagship.
- AdvarracoreAdvarra expanded its Study Collaboration solution to include integrations with eClinical technology partners including Suvoda. The integration creates a single sign-on (SSO) access point allowing sponsors, sites, and CROs to securely access multiple systems including IRT/RTSM through a unified interface. More than 225,000 study team members use the platform.
- GreenphireflagshipSuvoda and Greenphire completed their merger in April 2025, combining under the Suvoda name. The merger created a unified clinical trial technology platform integrating Greenphire's patient payment and travel solutions (ClinCard, ConneX travel service) with Suvoda's RTSM/IRT, eCOA, and eConsent products. The combined entity aims to provide end-to-end clinical trial technology and financial management, streamlining operations for sponsors, sites, and patients.
Scale indicators8 records
Recent moves9 records
Expansion highlights6 records
Suvoda competitors and assessment
Company assessmentDirect peers
- Veeva Systems: Veeva's Vault CTMS, Vault RTSM, and Vault eCOA directly compete with Suvoda's IRT/RTSM, eCOA, and eConsent offerings. Veeva is the largest publicly traded eClinical platform serving the same pharmaceutical sponsor and CRO customer base.
- Medidata Solutions (Dassault Systèmes): Medidata's Rave RTSM, Rave EDC, and eCOA solutions directly compete with Suvoda's core IRT, EDC-adjacent, and eCOA modules. Medidata serves the same enterprise pharma sponsors and CROs at comparable scale.
- Oracle Clinical One: Oracle's Clinical One platform combines RTSM, EDC, and clinical trial operations in a unified suite directly comparable to Suvoda's platform approach. Oracle leverages its broader enterprise software relationships to win large pharma accounts.
- Signant Health: Signant Health provides RTSM, eCOA, and clinical supply solutions that directly overlap Suvoda's core product portfolio. The company targets the same pharmaceutical and CRO customers and competes head-to-head on mid-sized and large trials.
- Clario: Clario offers eCOA, RTSM, cardiac safety, and imaging solutions that compete directly with Suvoda's patient-centric clinical outcome assessment and IRT offerings. Clario was formed from the merger of ERT and Bioclinica.
- Medrio: Medrio provides EDC, eCOA, and direct data capture solutions to clinical trial sponsors and CROs. It serves a comparable mid-market segment and overlaps with Suvoda's eCOA and trial configuration capabilities.
Emerging players
- Science 37: Science 37 pioneered decentralized clinical trial technology and competes in adjacent patient-facing and remote trial capabilities. Suvoda's unified patient app and Greenphire travel/payments overlap with Science 37's decentralized model.
- Advarra: Advarra's Study Collaboration platform integrates with Suvoda and competing eClinical technologies, offering site-facing workflow, IRB, and technology orchestration. The integration partnership (Dec 2025) and overlap in site payments/feasibility make it a relevant adjacent peer.
- Castor: Castor provides an eClinical platform with EDC, eCOA, and eConsent capabilities that competes in part with Suvoda's offering, particularly for smaller biotech and academic sponsors adopting cloud-based, configurable platforms.
Broad incumbents
- IQVIA: IQVIA operates as a broad CRO and clinical technology incumbent with proprietary RTSM, EDC, and analytics offerings. Its size and CRO relationships position it as both a customer and a competitor to Suvoda in the eClinical technology market.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Suvoda social profiles
Digital presenceSuvoda compliance and trust
Trust signalCompliance3 records
Suvoda financial estimates
Financial estimateRevenue estimate
Valuation estimate
Suvoda leadership team
Management profileNumber of profiles
Profiles11 records
Suvoda subsidiaries and ownership
Company hierarchySubsidiaries2 records
Suvoda funding detail
Funding detailFunding overview
Funding rounds1 record
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Suvoda M&A and investment
M&A and investmentM&A1 record
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Suvoda
What does Suvoda do?
Suvoda sells a unified, web-based clinical trial technology platform comprising eight modular products—RTSM/IRT, eCOA, eConsent, Patient Payments, Travel, Scheduling, Site Payments, and Budgeting & Benchmarking—delivered as multi-year enterprise SaaS subscriptions to pharmaceutical sponsors, CROs, and research sites. The platform is augmented by AI capabilities including the Sofia assistant and agentic RTSM, and supported by professional services for implementation, integration, and ongoing customer success.
Is Suvoda a public or private company?
Suvoda is a private company. It is classified as private equity controlled and is currently operating.
When was Suvoda founded?
Suvoda was founded in 2013. It employs 1,001 to 5,000 people.
Where is Suvoda based?
Suvoda is headquartered in Conshohocken, United States, in the North America region.
How does Suvoda make money?
One revenue line is on record: clinical Trial Software Platform.
Who are Suvoda's main competitors?
Direct peers on record are Veeva Systems, Medidata Solutions (Dassault Systèmes), Oracle Clinical One, Signant Health, Clario and Medrio. Emerging players are Science 37, Advarra and Castor. IQVIA is listed as a broad incumbent.
Does Suvoda have an API?
No public API is recorded for Suvoda.
What industry is Suvoda in?
Suvoda's product category is Clinical Trial Technology / eClinical Software. Its primary akta.pro industry code is HLAGAJAM, Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF), with a secondary code of HLACAOAJ, Site & Investigator Platforms (Site Payments, Feasibility, Activation). Its NAICS code is 513210 and its SIC code is 7372.